Skip to main content

Zecuity News

No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use

WEDNESDAY, May 21, 2025 – Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do not have increased...

Combination Therapy Recommended For Migraines

THURSDAY, March 20, 2025 – Doctors should prescribe triptans for migraine patients who aren’t receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from t...

FDA Medwatch Alert: Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars

ISSUE: FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic transdermal system) patch for migraine headaches. Since...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine

Zecuity patient information at Drugs.com